Australia Stock Exchange release from PARADIGM BIOPHAR : Phase 2 Synovial Fluid Biomarker Study Update
25/10/2021 23:21
Australia Stock Exchange release from PARADIGM BIOPHAR PAR.AX : Phase 2 Synovial Fluid Biomarker Study Update
Recent news on Paradigm Biopharmaceuticals
See all newsBrief: Paradigm Biopharmaceuticals Says Board Initiates Voluntary Administration
Brief: Paradigm Biopharmaceuticals Seeks Trading Halt
Australia's Paradigm Biopharmaceuticals slips on discounted placement
Brief: Paradigm Biopharmaceuticals Says Co Completes A$14 Mln Placement
Brief: Paradigm Biopharmaceuticals Requests Trading Halt